Fred Hassan is of BridgeBio Pharma, Inc.. Currently has a direct ownership of 19,300 shares of BBIO, which is worth approximately $534,803. The most recent transaction as insider was on Dec 29, 2021, when has been sold 19,300 shares (Common Stock) at a price of $14.17 per share, resulting in proceeds of $273,481. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 19.3K
0% 3M change
0% 12M change
Total Value Held $534,803

Fred Hassan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 29 2021
BUY
Open market or private purchase
$273,481 $14.17 p/Share
19,300 Added 50.0%
19,300 Common Stock

Also insider at

AMGN
AMGEN INC Healthcare
PGEN
PRECIGEN, INC. Healthcare
RXDX
Prometheus Biosciences, Inc. Healthcare
COCP
Cocrystal Pharma, Inc. Healthcare
EYPT
EyePoint Pharmaceuticals, Inc. Healthcare
FH

Fred Hassan

Thousand Oaks, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO